Efficacy of adjuvant chemotherapy with carboplatin for early triple negative breast cancer: a single center experience

BACKGROUND: Anthracycline- and taxane-based adjuvant chemotherapies are the most frequently used systemic treatments for women with triple negative breast cancer (TNBC). Adding platinum derivatives in the neo-adjuvant setting has been shown to not only improve the pCR rates, but also the 3 year DFS...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Vetter, Marcus, Fokas, Spyridon, Biskup, Ewelina, Schmid, Thomas, Schwab, Fabienne, Schoetzau, Andreas, Güth, Uwe, Rochlitz, Christoph, Zanetti-Dällenbach, Rosanna
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2017
Assuntos:
Clinical Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5650451/
https://ncbi.nlm.nih.gov/pubmed/29088896
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.18118
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados